EMA Recommends PreHevbri Hepatitis B Vaccine for Approval

The European Medicines Agency’s (EMA’s) human medicines committee has recommended approval of a hepatitis B vaccine for adults. The agency’s Committee for Medicinal Products for Human Use (CHMP) granted a positive opinion for PreHevbri on February 24 for active immunization against hepatitis B virus (HBV) infection. PreHevbri (PreHevBrio in the United States and Sci-B-Vac […]